Trial NCT01003938

View at ClinicalTrials.gov 
Org. Study IDs: NYU 08-613

Last trial update was posted on 2016-06-30

MeSH Interventions

Erlotinib Hydrochloride Topotecan

MeSH Conditions

Carcinoma, Ovarian Epithelial Ovarian Neoplasms

Other Conditions

Ovarian Cancer

Stopping Reasons

due to administrative issue and financial sponsor decision to suspend ovarian cancer studies

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID